CERo Therapeutics Holdings Inc (NASDAQ: CERO) open the trading on Wednesday, with great promise as it jumped 18.58% to $0.84, before settling in for the price of $0.70 at the close. Taking a more long-term approach, CERO posted a 52-week range of $0.65-$213.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
This publicly-traded company’s shares outstanding now amounts to $3.03 million, simultaneously with a float of $2.44 million. The organization now has a market capitalization sitting at $2.54 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3811, while the 200-day Moving Average is $9.9949.
CERo Therapeutics Holdings Inc (CERO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. CERo Therapeutics Holdings Inc’s current insider ownership accounts for 19.61%, in contrast to 8.56% institutional ownership. According to the most recent insider trade that took place on Dec 13 ’24, this organization’s 10% Owner sold 2,998,908 shares at the rate of 0.06, making the entire transaction reach 179,934 in total value, affecting insider ownership by 13,005,169. Preceding that transaction, on Dec 12 ’24, Company’s 10% Owner sold 1,614,541 for 0.07, making the whole transaction’s value amount to 113,018. This particular insider is now the holder of 16,004,077 in total.
CERo Therapeutics Holdings Inc (CERO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Let’s observe the current performance indicators for CERo Therapeutics Holdings Inc (CERO). It’s Quick Ratio in the last reported quarter now stands at 0.39. The Stock has managed to achieve an average true range (ATR) of 0.16.
In the same vein, CERO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -43.79.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
[CERo Therapeutics Holdings Inc, CERO] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 40.00% While, its Average True Range was 0.1245.
Raw Stochastic average of CERo Therapeutics Holdings Inc (CERO) in the period of the previous 100 days is set at 0.43%, which indicates a major fall in contrast to 50.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 102.09% that was lower than 204.42% volatility it exhibited in the past 100-days period.
